HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Lazabemide for the treatment of Alzheimer's disease: rationale and therapeutic perspectives.

AuthorsA M Cesura, E Borroni, J Gottowik, C Kuhn, P Malherbe, J Martin, J G Richards
JournalAdvances in neurology (Adv Neurol) Vol. 80 Pg. 521-8 ( 1999) ISSN: 0091-3952 [Print] United States
PMID10410766 (Publication Type: Journal Article, Review)
Chemical References
  • Monoamine Oxidase Inhibitors
  • Picolinic Acids
  • lazabemide
  • Monoamine Oxidase
Topics
  • Alzheimer Disease (drug therapy)
  • Animals
  • Brain (enzymology)
  • Humans
  • Mice
  • Mice, Transgenic (metabolism)
  • Monoamine Oxidase (drug effects, metabolism)
  • Monoamine Oxidase Inhibitors (therapeutic use)
  • Neurodegenerative Diseases (physiopathology)
  • Oxidative Stress (physiology)
  • Picolinic Acids (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: